Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multicenter 52 Weeks Double Blind Placebo-controlled Trial for the Assessment of Theophylline on Top of Combination Therapy in Severe COPD

NCT01599871 is registered in ClinicalTrials.gov with Hospital Son Espases as lead sponsor.

NCT NCT01599871
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01599871 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multicenter 52 Weeks Double Blind Placebo-controlled Trial for the Assessment of Theophylline on Top of Combination Therapy in Severe COPD
Lead sponsor
Hospital Son Espases
Phase
Phase 3
Overall status
Completed
Start date
January 31, 2011
Completion date
September 30, 2016
Enrollment
70 (actual)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

chronic obstructive pulmonary disease